Schedule 13D ownership disclosure

TARO PHARMACEUTICAL INDUSTRIES LTD

Security class unavailable · CUSIP: M8737E108

Event date: 2024-01-17

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
78.4800%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950103-24-000736
Form type
SC 13D/A
Filer
SUN PHARMACEUTICAL INDUSTRIES LTD
CIK
CIK 1197089
Filed
Jan 17, 2024
Reporting period
Jan 17, 2024
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub